2 completed, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Not yet recruiting 1 |
Follow Stevens-Johnson Syndrome: new trials by email Literature Review of Stevens-Johnson Syndrome trials Research Report on Stevens-Johnson Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness HLA-B*58:01 Genotyping, Allopurinol Tablet, Febuxostat - Gout Initiating Urate-loweringUrate-lowering Therapy, Gout Arthritis | Phase 4 | Not yet recruiting | Haiphong University of Medicine and Pharmacy | 228 | 2026-01-20 | 2026-01-27 |
| G-CSF in the Treatment of Toxic Epidermal Necrolysis recombinant granulocyte - colony stimulating factor, NaCl 0.9% - Stevens - Johnson Syndrome | Phase 4 | Completed | University of Liege | 10 | 2016-07-01 | 2025-12-31 |
| Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye 0.05%cyclosporin eye drop - Stevens-Johnson Syndrome | Phase 4 | Completed | Mahidol University | 31 | 2007-02-01 | 2011-12-08 |
Arthritis, Gouty (1) · Dry Eye Syndromes (1) · Gout (1) · Hyperuricemia (1)
Chemically-Induced Disorders (3) · Dermatitis (3) · Drug Eruptions (3) · Drug Hypersensitivity (3) · Drug-Related Side Effects and Adverse Reactions (3) · Erythema (3) · Erythema Multiforme (3) · Hypersensitivity (3) · Hypersensitivity, Delayed (3) · Immune System Diseases (3) · Mouth Diseases (3) · Skin Diseases (3) · Skin Diseases, Vesiculobullous (3) · Skin and Connective Tissue Diseases (3) · Stomatitis (3)
Allopurinol (1) · Cyclosporine (1) · Febuxostat (1) · Filgrastim (1) · Sodium Chloride (1)
Haiphong University of Medicine and Pharmacy (1) · Mahidol University (1) · University of Liege (1)
Belgium (1) · Thailand (1)